Nuveen ESG Small-Cap ETF
NUSC · ETF
About NUSC
- Issuer
- Nuveen
- Tracks
- MSCI Nuveen ESG USA Small Cap
- Expense ratio
- 0.31%
- Assets under management
- $1.27B
- Inception
- Dec 13, 2016
- Asset class
- Equity
- Website
- nuveen.com
NUSC key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 87.12K
- Volume
- 53.65K
- Open price
- $49.52
- High today
- $49.71
- Low today
- $49.22
- 52 Week high
- $53.30
- 52 Week low
- $42.11
Nuveen ESG Small-Cap ETF (NUSC) at a glance
Nuveen ESG Small-Cap ETF (NUSC) last traded at $49.57, with a market cap of 0 and a price-to-earnings ratio of 0.00.
Today the fund has traded between $49.22 and $49.71. The current price is 0.7% above the day's low and 0.3% below its high.
Volume so far is 53.65K shares, below the average of 87.12K shares a day.
Over the past year Nuveen ESG Small-Cap ETF has ranged from $42.11 to $53.30, and now sits 67% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.